Recent Updates
Recently added Catalysts
FULC Positive Sentiment Score: 70/100

Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Tuesday, February 6, 2024 1 min read
Key Takeaway: Fulcrum Therapeutics, a biopharmaceutical company dedicated to rare diseases, will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference. This virtual event is scheduled for February 13, 2024, at 1:20 p.m. ET, and will include one-on-one investor meetings. The presentation aims to provide insights into the company's corporate overview and strategic direction.

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is showcasing their progress at a prominent industry conference.
  • Management's participation indicates potential investor interest and engagement.
  • The event emphasizes the company's focus on rare diseases, which can attract attention from specialized investors.

Full Press Release Details

CAMBRIDGE, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will present a corporate overview at the Oppenheimer 34th Annual Healthcare Life Sciences Conference, being held virtually on Tuesday, February 13, 2024 at 1:20 p.m. ET. Management will also participate in one-on-one investor meetings.
The webcast of the presentation will be accessible here and by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.
About Fulcrum Therapeutics
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com

Frequently Asked Questions

When will Fulcrum Therapeutics present at the conference?

Fulcrum Therapeutics will present on February 13, 2024, at 1:20 p.m. ET.

How can I access the Fulcrum Therapeutics presentation?

The presentation can be accessed via their website's Events section.

Will there be a replay of the presentation available?

Yes, a replay will be available for at least 30 days post-presentation.

What type of company is Fulcrum Therapeutics?

Fulcrum Therapeutics focuses on developing small molecules for rare diseases.

Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics Oppenheimer healthcare conference rare diseases
Last updated: Feb 6, 2024